Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
RFA RCT for Pancreatic or Bile Duct Cancer
Not Applicable
Terminated
- Conditions
- Cholangiocarcinoma Non-resectableUnresectable Pancreatic Cancer
- Interventions
- Procedure: Radiofrequency Ablation using EndoHPB ProbeProcedure: Stenting only
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 8
- Registration Number
- NCT02166190
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Effect of CES on Parasympathetic Tone
Phase 4
Completed
- Conditions
- Autonomic Nervous System Imbalance
- Interventions
- Device: Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100)
- First Posted Date
- 2014-06-16
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 21
- Registration Number
- NCT02163967
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Changes Associated With H. Pylori and Gastric Carcinogenesis
Recruiting
- Conditions
- Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
- Interventions
- Procedure: Endoscopy tissue collection
- First Posted Date
- 2014-06-16
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 120
- Registration Number
- NCT02164409
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Peroral Endoscopic Myotomy (POEM) For The Treatment Of Achalasia: A Registry
- Conditions
- Achalasia
- Interventions
- Procedure: POEM
- First Posted Date
- 2014-06-12
- Last Posted Date
- 2017-02-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 200
- Registration Number
- NCT02162589
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Phase 1
Suspended
- Conditions
- Advanced Cancer
- Interventions
- Radiation: FDG
- First Posted Date
- 2014-05-05
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 4
- Registration Number
- NCT02130492
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
Not Applicable
Completed
- Conditions
- Tourette DisorderChronic Tic Disorder
- Interventions
- Behavioral: OTs Trained and Deliver CBIT
- First Posted Date
- 2014-04-15
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 13
- Registration Number
- NCT02114905
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Comparing Paper-based and Tablet-delivered Informed Consent for Older Adults
Not Applicable
Completed
- Conditions
- Tablet-delivered Informed ConsentPaper-based Informed Consent
- Interventions
- Other: Randomized- paper consentOther: Randomized- Tablet-delivered consentOther: Focus Group- paper and tablet consent
- First Posted Date
- 2014-04-15
- Last Posted Date
- 2016-08-16
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 40
- Registration Number
- NCT02114970
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome
Not Applicable
Completed
- Conditions
- Tourette SyndromeChronic Tic Disorder
- Interventions
- Device: Active Oral Orthotic TreatmentDevice: Placebo Oral Orthotic Treatment
- First Posted Date
- 2014-02-20
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 21
- Registration Number
- NCT02067819
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma
Phase 1
Completed
- Conditions
- Hodgkin's LymphomaNon-Hodgkin's Lymphoma
- Interventions
- Drug: BendamustineDrug: CarmustineDrug: EtoposideDrug: MelphalanDrug: CytarabineDrug: AlemtuzumabBiological: Autologous Stem Cell TransplantationBiological: Allogeneic Stem Cell TransplantationDrug: Rituximab
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 34
- Registration Number
- NCT02059239
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Efficacy of Quetiapine for Pediatric Delirium
- First Posted Date
- 2014-02-05
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 6
- Registration Number
- NCT02056171
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸NY Prebyterian Hospital/Weill Cornell Medical Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath